RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.8311
-0.0089 (-1.06%)
At close: Apr 29, 2026, 4:00 PM EDT
0.8477
+0.0166 (2.00%)
Pre-market: Apr 30, 2026, 7:18 AM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $37.44 million as of April 30, 2026. Its market cap has increased by 32.71% in one year.
Market Cap
37.44M
Enterprise Value
30.63M
1-Year Change
32.71%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $37.44M, a decrease of -45.45%. That is a compound annual growth rate of -12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 37.84M | 22.91% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 40.66M |
| Cue Biopharma | 40.55M |
| Sensei Biotherapeutics | 39.02M |
| Aligos Therapeutics | 38.92M |
| Atara Biotherapeutics | 38.68M |
| INmune Bio | 37.22M |
| Actinium Pharmaceuticals | 37.10M |
| Veru Inc. | 36.76M |